- Rational: Pharmacists are key members on the healthcare team and their presence during acute ischemic strokes (AIS) response can decrease the thrombolytic administration door-to-needle (DTN) time and improve outcomes.
-
Objectives: To quantify the reduction in thrombolytic administration door-to-needle time when a pharmacist is present verses when a pharmacist is absent during acute ischemic stroke response.
-
Research question: In patients presenting to United States emergency departments with acute ischemic stroke, does the presence of a pharmacist reduce the door-to-needle (DTN) time of fibrinolytic administration when compared to pharmacist absence?
Menu